Literature DB >> 23847811

Developing an in silico model of the modulation of base excision repair using methoxyamine for more targeted cancer therapeutics.

Evren Gurkan-Cavusoglu1, Sriya Avadhani, Lili Liu, Timothy J Kinsella, Kenneth A Loparo.   

Abstract

Base excision repair (BER) is a major DNA repair pathway involved in the processing of exogenous non-bulky base damages from certain classes of cancer chemotherapy drugs as well as ionising radiation (IR). Methoxyamine (MX) is a small molecule chemical inhibitor of BER that is shown to enhance chemotherapy and/or IR cytotoxicity in human cancers. In this study, the authors have analysed the inhibitory effect of MX on the BER pathway kinetics using a computational model of the repair pathway. The inhibitory effect of MX depends on the BER efficiency. The authors have generated variable efficiency groups using different sets of protein concentrations generated by Latin hypercube sampling, and they have clustered simulation results into high, medium and low efficiency repair groups. From analysis of the inhibitory effect of MX on each of the three groups, it is found that the inhibition is most effective for high efficiency BER, and least effective for low efficiency repair.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23847811      PMCID: PMC3884826          DOI: 10.1049/iet-syb.2011.0045

Source DB:  PubMed          Journal:  IET Syst Biol        ISSN: 1751-8849            Impact factor:   1.615


  60 in total

Review 1.  Initiation of base excision repair: glycosylase mechanisms and structures.

Authors:  A K McCullough; M L Dodson; R S Lloyd
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Base excision repair in a network of defence and tolerance.

Authors:  H Nilsen; H E Krokan
Journal:  Carcinogenesis       Date:  2001-07       Impact factor: 4.944

3.  Protection against methylation-induced cytotoxicity by DNA polymerase beta-dependent long patch base excision repair.

Authors:  J K Horton; R Prasad; E Hou; S H Wilson
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

4.  Rates of base excision repair are not solely dependent on levels of initiating enzymes.

Authors:  E Cappelli; T Hazra; J W Hill; G Slupphaug; M Bogliolo; G Frosina
Journal:  Carcinogenesis       Date:  2001-03       Impact factor: 4.944

5.  Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1.

Authors:  F Dantzer; G de La Rubia; J Ménissier-De Murcia; Z Hostomsky; G de Murcia; V Schreiber
Journal:  Biochemistry       Date:  2000-06-27       Impact factor: 3.162

6.  Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.

Authors:  L Liu; P Taverna; C M Whitacre; S Chatterjee; S L Gerson
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

7.  Human DNA polymerase beta initiates DNA synthesis during long-patch repair of reduced AP sites in DNA.

Authors:  A J Podlutsky; I I Dianova; V N Podust; V A Bohr; G L Dianov
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 8.  Recent progress in the biology, chemistry and structural biology of DNA glycosylases.

Authors:  O D Schärer; J Jiricny
Journal:  Bioessays       Date:  2001-03       Impact factor: 4.345

9.  Fidelity of nucleotide insertion at 8-oxo-7,8-dihydroguanine by mammalian DNA polymerase delta. Steady-state and pre-steady-state kinetic analysis.

Authors:  H J Einolf; F P Guengerich
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

10.  Essential role of DNA base excision repair on survival in an acidic tumor microenvironment.

Authors:  Yuji Seo; Timothy J Kinsella
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701

View more
  1 in total

1.  Prediction of drug synergy score using ensemble based differential evolution.

Authors:  Harpreet Singh; Prashant Singh Rana; Urvinder Singh
Journal:  IET Syst Biol       Date:  2019-02       Impact factor: 1.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.